<bill session="118" type="s" number="5046" updated="2025-08-04T19:09:12Z">
  <state datetime="2024-12-12">PASS_OVER:SENATE</state>
  <status>
    <unknown datetime="2024-12-12"/>
  </status>
  <introduced datetime="2024-09-12"/>
  <titles>
    <title type="display">FDA Modernization Act 3.0</title>
    <title type="short" as="introduced">FDA Modernization Act 3.0</title>
    <title type="short" as="passed senate">FDA Modernization Act 3.0</title>
    <title type="official" as="introduced">A bill to require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.</title>
  </titles>
  <sponsor bioguide_id="B001288"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2024-09-12"/>
    <cosponsor bioguide_id="B001310" joined="2024-09-12"/>
    <cosponsor bioguide_id="K000393" joined="2024-09-12"/>
    <cosponsor bioguide_id="K000383" joined="2024-09-12"/>
    <cosponsor bioguide_id="L000570" joined="2024-09-12"/>
    <cosponsor bioguide_id="M001198" joined="2024-11-12"/>
    <cosponsor bioguide_id="P000603" joined="2024-09-12"/>
    <cosponsor bioguide_id="S001227" joined="2024-09-12"/>
    <cosponsor bioguide_id="W000802" joined="2024-09-12"/>
  </cosponsors>
  <actions>
    <action datetime="2024-09-12">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2024-09-12" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2024-12-12">
      <text>Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.</text>
    </action>
    <action datetime="2024-12-12">
      <text>Measure laid before Senate by unanimous consent.</text>
      <reference ref="CR S7044" label="consideration"/>
    </action>
    <vote how="by Unanimous Consent" type="vote" datetime="2024-12-12" where="s" result="pass" state="PASS_OVER:SENATE">
      <text>Passed Senate with an amendment by Unanimous Consent.</text>
      <reference ref="CR S7044" label="text of amendment in the nature of a substitute"/>
    </vote>
    <action datetime="2024-12-13">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2024-12-16T12:11:08-05:00">
      <text>Received in the House.</text>
    </action>
    <action datetime="2024-12-16T14:40:35-05:00">
      <text>Held at the desk.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Discharged From, Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="7248" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Medical research"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments>
    <amendment number="s3328"/>
  </amendments>
  <summary date="2025-08-04T19:08:41Z" status="Passed Senate">FDA Modernization Act 3.0

This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.&#160;

The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA&#226;&#8364;&#8482;s regulations governing investigational new drug applications, and may make other changes to the regulations as appropriate.&#160;

The rule must be published within one year of the bill&#226;&#8364;&#8482;s enactment, and must take immediate effect as an interim final rule.&#160;</summary>
</bill>
